Skip to main content

30.04.2016 | Review Article | Ausgabe 6/2016

Drugs & Aging 6/2016

Therapeutic Potential of Antidiabetic Medications in the Treatment of Cognitive Dysfunction and Dementia

Drugs & Aging > Ausgabe 6/2016
Hiroyuki Umegaki


It has been established that diabetes mellitus (DM) is a risk factor for dementia, and recent studies have clearly shown that dementia is one of the complications of DM. The increase of cognitively impaired subjects with the progression of aging in the population is an urgent worldwide issue. Due to the pharmacological advancement in the field of DM, we now have many kinds of antidiabetic medications with a wide variety of mechanisms of action and characteristics. It is a good time to review the characteristics of each antidiabetic medication and the evidence related to their prevention of cognitive dysfunction or preservation of cognition. The available data on the effects of antidiabetics on cognitive dysfunction and dementia show that several of the antidiabetics have the potential to improve cognition. The accumulation of more data to determine the best ways to use antidiabetics in order to prevent cognitive impairment would be warranted. To this end, the present review will try to illustrate the horizon of achievement in this field.

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

e.Med Interdisziplinär

Mit e.Med Interdisziplinär erhalten Sie Zugang zu allen CME-Fortbildungen und Fachzeitschriften auf

Über diesen Artikel

Weitere Artikel der Ausgabe 6/2016

Drugs & Aging 6/2016 Zur Ausgabe

Neu im Fachgebiet Innere Medizin

Mail Icon II Newsletter

Bestellen Sie unseren kostenlosen Newsletter Update Innere Medizin und bleiben Sie gut informiert – ganz bequem per eMail.

© Springer Medizin